BidaskClub lowered shares of LivaNova PLC (NASDAQ:LIVN) from a buy rating to a hold rating in a research note released on Tuesday, August 1st.
LivaNova PLC (NASDAQ LIVN) opened at 60.86 on Tuesday. The firm has a market cap of $2.97 billion, a price-to-earnings ratio of 108.68 and a beta of 0.62. LivaNova PLC has a 52-week low of $40.83 and a 52-week high of $64.95. The company has a 50 day moving average price of $61.56 and a 200-day moving average price of $55.58.
LivaNova PLC (NASDAQ:LIVN) last announced its quarterly earnings data on Wednesday, August 9th. The company reported $1.01 EPS for the quarter, topping analysts’ consensus estimates of $0.82 by $0.19. LivaNova PLC had a return on equity of 9.08% and a net margin of 2.26%. The business had revenue of $321.40 million during the quarter, compared to analysts’ expectations of $315.75 million. LivaNova PLC’s revenue for the quarter was up .1% on a year-over-year basis. Equities research analysts anticipate that LivaNova PLC will post $3.20 EPS for the current year.
ILLEGAL ACTIVITY WARNING: This news story was reported by BNB Daily and is the property of of BNB Daily. If you are accessing this news story on another publication, it was illegally copied and republished in violation of United States and international trademark and copyright laws. The legal version of this news story can be viewed at https://www.baseball-news-blog.com/2017/08/19/livanova-plc-livn-lowered-to-hold-at-bidaskclub-updated-updated.html.
In related news, Director Sharon O’kane acquired 1,000 shares of the firm’s stock in a transaction that occurred on Tuesday, May 23rd. The stock was acquired at an average cost of $58.58 per share, with a total value of $58,580.00. Following the completion of the purchase, the director now directly owns 1,000 shares in the company, valued at $58,580. The purchase was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. Over the last ninety days, insiders have sold 4,000 shares of company stock valued at $241,600. 0.28% of the stock is owned by insiders.
A number of hedge funds and other institutional investors have recently bought and sold shares of the stock. Mason Street Advisors LLC boosted its position in LivaNova PLC by 0.3% in the first quarter. Mason Street Advisors LLC now owns 20,484 shares of the company’s stock worth $1,004,000 after buying an additional 64 shares during the last quarter. Louisiana State Employees Retirement System boosted its position in LivaNova PLC by 0.9% in the first quarter. Louisiana State Employees Retirement System now owns 10,900 shares of the company’s stock worth $534,000 after buying an additional 100 shares during the last quarter. PNC Financial Services Group Inc. boosted its position in LivaNova PLC by 9.8% in the second quarter. PNC Financial Services Group Inc. now owns 1,707 shares of the company’s stock worth $105,000 after buying an additional 153 shares during the last quarter. Advantus Capital Management Inc boosted its position in LivaNova PLC by 3.3% in the first quarter. Advantus Capital Management Inc now owns 5,551 shares of the company’s stock worth $272,000 after buying an additional 176 shares during the last quarter. Finally, Oregon Public Employees Retirement Fund boosted its position in LivaNova PLC by 1.3% in the first quarter. Oregon Public Employees Retirement Fund now owns 15,360 shares of the company’s stock worth $753,000 after buying an additional 200 shares during the last quarter. 75.01% of the stock is owned by hedge funds and other institutional investors.
LivaNova PLC Company Profile
LivaNova PLC is a medical device company focused on the development and delivery of therapeutic solutions. The Company’s segments include Cardiac Surgery, Cardiac Rhythm Management, Neuromodulation and Other. The Cardiac Surgery segment is engaged in the development, production and sale of cardiovascular surgery products.
Receive News & Ratings for LivaNova PLC Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for LivaNova PLC and related companies with MarketBeat.com's FREE daily email newsletter.